Discovery of novel aporphine alkaloid derivative as potent TLR2 antagonist reversing macrophage polarization and neutrophil infiltration against acute inflammation-Reference-Cited by-同舟云学术

Discovery of novel aporphine alkaloid derivative as potent TLR2 antagonist reversing macrophage polarization and neutrophil infiltration against acute inflammation

Published:2023-09 Issue:9 Volume:13 Page:3782-3801
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Yang Junjie,Pan Yue,Zeng Xiaoshan,Liu Shuwen,Chen Zhipeng,Cheng Kui^ORCID

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Guangzhou Municipal Science and Technology Program key projects

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference45 articles.

1. Trained immunity: a program of innate immune memory in health and disease;Netea;Science,2016

2. Targeting innate immunity for tuberculosis vaccination;Khader;J Clin Invest,2019

3. The impact of vaccines on heterologous adaptive immunity;Messina;Clin Microbiol Infect,2019

4. BCG-induced protection: effects on innate immune memory;Netea;Semin Immunol,2014

5. DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation;Zindel;Annu Rev Pathol,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of 3-bromoflavone derivative D5 as a novel TLR4-MD2 antagonist for treatment of acute lung injury and sepsis;Journal of Molecular Structure;2024-12

2. Identification of toll-like receptor 2 as a key regulator of neuronal apoptosis in vascular dementia by bioinformatics analysis and experimental validation;Experimental Gerontology;2024-08

3. Pretheranostic agents with extraordinaryNIRF/photoacoustic imaging performanceand photothermal oncotherapy efficacy;Acta Pharmaceutica Sinica B;2024-07

4. Enzyme-responsive design combined with photodynamic therapy for cancer treatment;Drug Discovery Today;2024-05

5. Discovery of an ellipticine derivative as TLR3 inhibitor against influenza A virus and SARS-CoV-2;Bioorganic & Medicinal Chemistry Letters;2024-03